Microbial resistance has reached alarming levels, threatening to outpace the ability to counter with more potent antimicrobial agents. In particular, methicillin-resistant Staphylococcus aureus (MRSA) has become a leading cause of skin and soft-tissue infections and PVL-positive strains have been associated with necrotizing pneumonia. Increasing reports of growing resistance to glycopeptides have been noted, further limiting…
Clinical Medicine Reviews in Therapeutics Template
Write in a clean editor, then format for Clinical Medicine Reviews in Therapeutics in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Medicine Reviews in Therapeutics format
Clinical Medicine Reviews in Therapeutics is a peer-reviewed journal published by SAGE, covering Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Antibiotic Resistance in Bacteria.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Reviews in Therapeutics, 12(3), pp. 45–58.
Formats any DOI in Clinical Medicine Reviews in Therapeutics style. No sign-up. |
| Publishes research in | Antibiotics Pharmacokinetics and Efficacy Antimicrobial Resistance in Staphylococcus Antibiotic Resistance in Bacteria Pneumonia and Respiratory Infections Asthma and respiratory diseases |
| ISSN | 1179-2558 |
| h-index | 5 |
| i10-index | 4 |
| Total citations | 228 |
| Top institutions publishing here | University of Minnesota |
| Journal website | clockss.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Medicine Reviews in Therapeutics per year
Citation impact of Clinical Medicine Reviews in Therapeutics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Medicine Reviews in Therapeutics
Zidovudine and lamivudine (ZDV and 3TC) are long-standing nucleoside analog-reverse transcriptase inhibitors (NRTIs) with extensive clinical experience in a wide spectrum of patients from in utero through childhood and adult ages. The safety profiles of both drugs are well-known and side effects for ZDV most commonly include nausea/vomiting, fatigue, anemia/neutopenia, and lipoatrophy; while 3TC is…
Hyaluronic acid (HA) is a linear naturally occurring polysaccharide formed from repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronate. HA is omnipresent in the human body but highest amounts are found in soft connective tissues. HA is involved in several key processes, including wound repair, regeneration, and matrix organization. To increase stability, modifications of HA like…
The hunt for a compound which inhibits the HIV-1 integrase had been painstakingly difficult. Integrase is essential for viral replication as it mediates the integration of the viral DNA genome into the host DNA resulting in the establishment of the permanent provirus. Persistent efforts have resulted in the discovery of Raltegravir (Isentress, MK-0518), the first…
The use of fosfomycin has been limited in therapeutics in recent years. Because it has shown good antibacterial activity in vitro and clinical efficacy in some domains, it has been proposed as an alternative to current antimicrobial agents, which are subject to increasing resistance. This paper reviews the main properties of fosfomycin and the latest…